Artivion
Atlanta, United States · Biotechnology, Healthcare, Health Care
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vasc
Key facts
- Headquarters
- Atlanta, United States
- Employees
- 1,600
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (AORT)
- Website
- artivion.com
- Company page
Recent activity at Artivion
- : Artivion, Inc. Completes Acquisition of Endospan Ltd.
- : Artivion to acquire Endospan for $335 million
- : SEC 8-K (2.01): On May 18, 2026, Artivion, Inc. announced the completion of its acquisition of Endospan Ltd., an Israeli corporation specializing in innovative products for the treatment of aortic instability. This acquisition includes the Nexus™ product line, which is significant for Artivion's portfolio and market position in the medical device sector. The financial terms of the acquisition were not disclosed in the press release. This strategic move aims to enhance Artivion's product offerings and reinforce its commitment to delivering advanced solutions in cardiovascular care.
- : SEC 8-K (5.02): At the Annual Meeting of Stockholders for Artivion, Inc. held on May 12, 2026, stockholders elected all nominated directors to serve until the next annual meeting. The meeting also involved a non-binding vote where stockholders approved the compensation for named executive officers, which included discussions and tables of their compensation. Additionally, stockholders ratified the selection of Ernst & Young LLP as the independent public accounting firm for the year ending December 31, 2026. This approval is significant as it sets the direction for the company's governance and future financial oversight.
- : CRYOLIFE INC
- : CRYOLIFE INC
Artivion funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2020 | Venture | $20.0M |
| Jan 2016 | Venture | $39.0M |
Leadership
- J. Mackin, Executive Officer, Director
- Thomas Ackerman, Director
- Daniel Bevevino, Director
- Marna Borgstrom, Director
- James Bullock, Director
- Jeffrey Burbank, Director
- Ronald McCall, Director
- Harvey Morgan, Director
- Jon Salveson, Director
- Jon Salveson, Director
- Harvey Morgan, Director
- Ronald McCall, Director
Verified email and direct lines for Artivion’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Artivion files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Artivion in the news
- Artivion Announces U.S. FDA Approval of the AMDS Hybrid Prosthesis - PR Newswire (Jun 29, 2026)
- Artivion closes Endospan buyout to acquire recently approved heart device - MedTech Dive (May 19, 2026)
- Artivion closes $175M acquisition of aortic arch maker Endospan - MassDevice (May 18, 2026)
- Artivion (AORT) Q1 2026 Earnings Transcript - The Motley Fool (May 07, 2026)
- Artivion’s aortic stents boost post-surgical outcomes in interventional studies - Clinical Trials Arena (Feb 03, 2026)
- Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System - PR Newswire (Apr 07, 2026)
- How Artivion’s Softer 2026 Outlook After Q1 Profit Turn Will Impact Artivion (AORT) Investors - Yahoo Finance (May 10, 2026)
- 2022's The Big 100: Artivion - The World’s Largest Medical Device Companies - Medical Design & Outsourcing (Aug 16, 2022)
Companies similar to Artivion
- Tenon Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Monteris Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- RIVANNA · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Dror Ortho-Design · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Treace · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
About Artivion: questions and answers
What does Artivion do?
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vasc
Where is Artivion headquartered?
Artivion is headquartered in Atlanta, United States.
How many employees does Artivion have?
Artivion has about 1,600 employees.
Has Artivion raised funding?
Yes. Fundz has recorded 2 funding events for Artivion. The most recent, $20.0M, was in Sep 2020.
What is the latest news on Artivion?
On May 18, 2026, Artivion, Inc. Completes Acquisition of Endospan Ltd.
Is Artivion a public company?
Yes. Artivion is publicly traded under the ticker AORT.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy